Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 122, Issue 8
August 22 2013
Issue Cover

Table of Contents

INSIDE BLOOD

THROMBOSIS & HEMOSTASIS
One inositol ring to rule thrombosis
James H. Morrissey
View Articletitled, One inositol ring to rule thrombosis
CLINICAL TRIALS & OBSERVATIONS
Transplants for the elderly in myeloma
Clinical Trials & Observations
Gareth J. Morgan
View Articletitled, Transplants for the elderly in myeloma
MYELOID NEOPLASIA
Precision ‘re’arming of CD33 antibodies
Gautam Borthakur
View Articletitled, Precision ‘re’arming of CD33 antibodies
TRANSFUSION MEDICINE
A mouse model of hemolytic disease of the newborn
Chance John Luckey,Leslie E. Silberstein
View Articletitled, A mouse model of hemolytic disease of the newborn
TRANSPLANTATION
Paneth cells in gut GVHD: a Panglossian perspective
John Koreth
View Articletitled, Paneth cells in gut GVHD: a Panglossian perspective
VASCULAR BIOLOGY
PRCP regulates angiogenesis in vivo
Martin Hagedorn
View Articletitled, PRCP regulates angiogenesis in vivo

BLOOD WORK

Reed Sternberg cells in bone marrow touch imprints
Bushra Moiz,Sidra Asad
View Articletitled, Reed Sternberg cells in bone marrow touch imprints
Pure white cell aplasia in a patient with thymic carcinoma
Payal C. Desai,Patricia Jones
View Articletitled, Pure white cell aplasia in a patient with thymic carcinoma

PLENARY PAPER

Toward eliminating HLA class I expression to generate universal cells from allogeneic donors
Hiroki Torikai,Andreas Reik,Frank Soldner,Edus H. Warren,Carrie Yuen,Yuanyue Zhou,Denise L. Crossland,Helen Huls,Nicholas Littman,Ziying Zhang,Scott S. Tykodi,Partow Kebriaei,Dean A. Lee,Jeffrey C. Miller,Edward J. Rebar,Michael C. Holmes,Rudolf Jaenisch,Richard E. Champlin,Philip D. Gregory,Laurence J. N. Cooper
View Articletitled, Toward eliminating HLA class I expression to generate universal cells from allogeneic donors
Supplemental data

REVIEW ARTICLE

Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature
Barbara Kiesewetter,Markus Raderer
View Articletitled, Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature
Regulation of platelet plug formation by phosphoinositide metabolism
Sang H. Min,Charles S. Abrams
View Articletitled, Regulation of platelet plug formation by phosphoinositide metabolism

HOW I TREAT

How I treat older patients with ALL
Nicola Gökbuget
View Articletitled, How I treat older patients with ALL

CLINICAL TRIALS AND OBSERVATIONS

Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results
Clinical Trials & Observations
Francesca Gay,Valeria Magarotto,Claudia Crippa,Norbert Pescosta,Tommasina Guglielmelli,Federica Cavallo,Sara Pezzatti,Samantha Ferrari,Anna Marina Liberati,Stefania Oliva,Francesca Patriarca,Massimo Offidani,Paola Omedé,Vittorio Montefusco,Maria Teresa Petrucci,Nicola Giuliani,Roberto Passera,Giuseppe Pietrantuono,Mario Boccadoro,Paolo Corradini,Antonio Palumbo
View Articletitled, Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results
Supplemental data
Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival
Clinical Trials & Observations
Alan K. Burnett,Nigel H. Russell,Ann E. Hunter,Donald Milligan,Steven Knapper,Keith Wheatley,John Yin,Mary F. McMullin,Sahra Ali,David Bowen,Robert K. Hills,on behalf of the UK National Cancer Research Institute AML Working Group
View Articletitled, Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival
Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report
Brief Report
Ayalew Tefferi,Francisco Cervantes,Ruben Mesa,Francesco Passamonti,Srdan Verstovsek,Alessandro M. Vannucchi,Jason Gotlib,Brigitte Dupriez,Animesh Pardanani,Claire Harrison,Ronald Hoffman,Heinz Gisslinger,Nicolaus Kröger,Juergen Thiele,Tiziano Barbui,Giovanni Barosi
View Articletitled, Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report
Supplemental data

GENE THERAPY

Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes
Daniel Abate-Daga,Ken-ichi Hanada,Jeremy L. Davis,James C. Yang,Steven A. Rosenberg,Richard A. Morgan
View Articletitled, Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes
Supplemental data

IMMUNOBIOLOGY

Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage
André Cohnen,Samuel C. Chiang,Ana Stojanovic,Hendrik Schmidt,Maren Claus,Paul Saftig,Ottmar Janßen,Adelheid Cerwenka,Yenan T. Bryceson,Carsten Watzl
View Articletitled, Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage
Supplemental data
Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2–dependent prostaglandin E2 in human dendritic cells
Jamma Trinath,Pushpa Hegde,Meenu Sharma,Mohan S. Maddur,Magalie Rabin,Jean-Michel Vallat,Laurent Magy,Kithiganahalli N. Balaji,Srini V. Kaveri,Jagadeesh Bayry
View Articletitled, Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2–dependent prostaglandin E2 in human dendritic cells
The β2 integrin–kindlin-3 interaction is essential for T-cell homing but dispensable for T-cell activation in vivo
Vicky Louise Morrison,Matthew MacPherson,Terhi Savinko,Hwee San Lek,Alan Prescott,Susanna Carola Fagerholm
View Articletitled, The β2 integrin–kindlin-3 interaction is essential for T-cell homing but dispensable for T-cell activation in vivo
An evolutionarily conserved program of B-cell development and activation in zebrafish
e-blood
Dawne M. Page,Valerie Wittamer,Julien Y. Bertrand,Kanako L. Lewis,David N. Pratt,Noemi Delgado,Sarah E. Schale,Caitlyn McGue,Bradley H. Jacobsen,Alyssa Doty,Yvonne Pao,Hongbo Yang,Neil C. Chi,Brad G. Magor,David Traver
View Articletitled, An evolutionarily conserved program of B-cell development and activation in zebrafish
Supplemental data

LYMPHOID NEOPLASIA

RARα2 expression confers myeloma stem cell features
Ye Yang,Jumei Shi,Giulia Tolomelli,Hongwei Xu,Jiliang Xia,He Wang,Wen Zhou,Yi Zhou,Satyabrata Das,Zhimin Gu,Dana Levasseur,Fenghuang Zhan,Guido Tricot
View Articletitled, RARα2 expression confers myeloma stem cell features
Supplemental data
HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma
Miguel Alcoceba,Elena Sebastián,Luis Marín,Ana Balanzategui,M. Eugenia Sarasquete,M. Carmen Chillón,Cristina Jiménez,Noemí Puig,Rocío Corral,Emilia Pardal,Carlos Grande,José Luis Bello,Carmen Albo,Fátima de la Cruz,Carlos Panizo,Alejandro Martín,Eva González-Barca,M. Dolores Caballero,Jesús F. San Miguel,Ramón García-Sanz,Marcos González
View Articletitled, HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma
Supplemental data

MYELOID NEOPLASIA

SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
May S. Kung Sutherland,Roland B. Walter,Scott C. Jeffrey,Patrick J. Burke,Changpu Yu,Heather Kostner,Ivan Stone,Maureen C. Ryan,Django Sussman,Robert P. Lyon,Weiping Zeng,Kimberly H. Harrington,Kerry Klussman,Lori Westendorf,David Meyer,Irwin D. Bernstein,Peter D. Senter,Dennis R. Benjamin,Jonathan G. Drachman,Julie A. McEarchern
View Articletitled, SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
Supplemental data
JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNα
Salma Hasan,Catherine Lacout,Caroline Marty,Marie Cuingnet,Eric Solary,William Vainchenker,Jean-Luc Villeval
View Articletitled, JAK2<sup>V617F</sup> expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNα
Supplemental data

THROMBOSIS AND HEMOSTASIS

Inositol hexakisphosphate kinase 1 maintains hemostasis in mice by regulating platelet polyphosphate levels
Somadri Ghosh,Dhananjay Shukla,Komjeti Suman,B. Jyothi Lakshmi,R. Manorama,Satish Kumar,Rashna Bhandari
View Articletitled, Inositol hexakisphosphate kinase 1 maintains hemostasis in mice by regulating platelet polyphosphate levels
Supplemental data
Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome
Shuju Feng,Stephen J. Eyler,Yuzhou Zhang,Tara Maga,Carla M. Nester,Michael H. Kroll,Richard J. Smith,Vahid Afshar-Kharghan
View Articletitled, Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome
Supplemental data

TRANSFUSION MEDICINE

Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model
Sean R. Stowell,Kate L. Henry,Nicole H. Smith,Krystalyn E. Hudson,Greg R. Halverson,Jaekeun C. Park,Ashley M. Bennett,Kathryn R. Girard-Pierce,C. Maridith Arthur,Silvia T. Bunting,James C. Zimring,Jeanne E. Hendrickson
View Articletitled, Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model

TRANSPLANTATION

Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality
John E. Levine,Elisabeth Huber,Suntrea T. G. Hammer,Andrew C. Harris,Joel K. Greenson,Thomas M. Braun,James L. M. Ferrara,Ernst Holler
View Articletitled, Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality
Supplemental data
Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial
Corey Cutler,Haesook T. Kim,Bhavjot Bindra,Stefanie Sarantopoulos,Vincent T. Ho,Yi-Bin Chen,Jacalyn Rosenblatt,Sean McDonough,Phandee Watanaboonyongcharoen,Philippe Armand,John Koreth,Brett Glotzbecker,Edwin Alyea,Bruce R. Blazar,Robert J. Soiffer,Jerome Ritz,Joseph H. Antin
View Articletitled, Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial
Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses
Brief Report
Can M. Sungur,Yajarayma J. Tang-Feldman,Anthony E. Zamora,Maite Alvarez,Claire Pomeroy,William J. Murphy
View Articletitled, Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses
Supplemental data

VASCULAR BIOLOGY

Prolylcarboxypeptidase promotes angiogenesis and vascular repair
Gregory N. Adams,Evi X. Stavrou,Chao Fang,Alona Merkulova,M. Amer Alaiti,Kohsuke Nakajima,Toshifumi Morooka,Sergei Merkulov,Gretchen A. LaRusch,Daniel I Simon,Mukesh K. Jain,Alvin H. Schmaier
View Articletitled, Prolylcarboxypeptidase promotes angiogenesis and vascular repair
Supplemental data

ERRATA

Whelihan MF, Zachary V, Orfeo T, Mann KG. Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation. Blood. 2012;120(18):3837-3845.
View Articletitled, Whelihan MF, Zachary V, Orfeo T, Mann KG. Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation. <em>Blood</em>. 2012;120(18):<span class="related-article">3837-3845</span>.
  • Cover Image

    Cover Image

    issue cover

    Immunofluorescence staining of developing microvasculature in a Matrigel plug in the flank of a wild-type mouse. The red-orange material is CD31; the green stain is NG2, a chondroitin 4 epitope that is a marker for vascular smooth muscle cells; and the yellow color is their colocalization. The balanced NG2/CD31 antigen ratio seen in this photomicrograph is contrasted with that seen in Matrigel plugs in PRCPgt/gt mice. Prolylcarboxypeptidase (PRCP) deficient cells have reduced endothelial cell growth and migration. PRCP deficient mice (PRCPgt/gt) have reduced angiogenesis and reduced the ability for ischemic repair. See the article by Adams et al on page 1522.

  • PDF Icon PDF LinkFront Matter
  • PDF Icon PDF LinkTable of Contents
  • PDF Icon PDF LinkBack Matter
  • PDF Icon PDF LinkAdvertising
  • PDF Icon PDF LinkEditorial Board
All Issues

Advertisement

EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical endpoint for multiple myeloma
Increased risk of venous thromboembolism in young and middle-aged individuals with hereditary angioedema: a family study
Data mining for second malignancies after CAR-T
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study
Mutational profile of previously treated chronic lymphocytic leukemia patients progressing on acalabrutinib or ibrutinib

Advertisement

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement